Komori
EnBio Holdings,Inc (6092) · RiskWorsened

Financial Covenants on Borrowings and Acceleration

First written in FY2016. 6 of 10 entries say "Worsened", first in FY2017. Latest entry: FY2026.

10entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2017 – FY2019MitigatedFY2020-Q2 – FY2020-Q3WorsenedFY2023 – FY20262016: 120162017: 120172018: 020182019: 220192020: 120202021: 120212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Risk of Loss of Benefit of Time Due to Breach of Financial CovenantsA theme 287 companies write about · 291 as a headwind · 0 as a tailwind

EnBio Holdings,Inc moved to the "Worse" side of this theme in 2023, the same year as the typical company in this theme.

16 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 293 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2026, ¥8,003 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants increased from ¥6,456 million in the previous fiscal year to ¥8,003 million.
  2. FY2025WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2025, ¥6,456.406 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants increased from ¥5,533.594 million in the previous consolidated fiscal year to ¥6,456.406 million.
  3. FY2023WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2023, ¥5,978.634 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants increased from ¥5,740.127 million in the previous fiscal year to ¥5,978.634 million.
  4. FY2022MitigatedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2022, ¥5,740.127 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants decreased from ¥6,088.332 million in the previous fiscal year to ¥5,740.127 million.
  5. FY2021WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2021, ¥6,088.332 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants increased from ¥5,832.472 million in the previous fiscal year to ¥6,088.332 million.
  6. FY2020-Q3MitigatedAnnual report

    「In connection with the repayment of these borrowings, totalling ¥3,687 million, the equity ratio improved to 34.1%, from 23.9% at the end of the previous consolidated fiscal year.」

    The equity ratio after repayment of borrowings was 34.1%, improving further from the 32.7% reported in the previous quarter.
  7. FY2020-Q2MitigatedAnnual report

    「In connection with the repayment of these borrowings, totalling ¥3,687 million, the equity ratio improved to 32.7%, from 23.9% at the end of the previous consolidated fiscal year.」

    Repayment of borrowings funded by the proceeds from the transfer of solar power-generation facilities improved the outstanding borrowing balance and equity ratio, reducing borrowing exposure that could be subject to financial covenants.
  8. FY2019WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2019, ¥9,417.644 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants amounted to ¥9,417.644 million, up from ¥9,105.635 million in the previous consolidated fiscal year.
  9. FY2017WorsenedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2017, ¥4,187.453 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    Borrowings subject to financial covenants increased from ¥2,363.000 million in the previous fiscal year to ¥4,187.453 million.
  10. FY2016First statedAnnual report

    「Of the borrowings outstanding for the consolidated fiscal year ended 31 March 2016, ¥2,363 million is subject to certain financial covenants concerning net assets and ordinary profit.」

    The company states that the borrowings may become repayable in full if the financial covenants concerning net assets and ordinary profit are breached.
Moved together

"Delayed China Market Ramp-Up and Affiliate Losses" moved the same way as this thread, in the same document, in 7 of its 10 moves.

754444★123456
  1. ★This thread
  2. 1Delayed China Market Ramp-Up and Affiliate Losses7×
  3. 2Project Schedule Delays and Construction-Cost Fluctuations Due to Contamination Conditions5×
  4. 3Expansion of Renewable Energy Business4×
  5. 4Increase in consolidated net sales and return to profitability4×
  6. 5Foreign-Exchange, Country and Investment Loss Risks Associated with Overseas Investments4×
  7. 6Medium-Term Management Plan Targeting the Fiscal Year Ending March 20224×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for EnBio Holdings,Inc yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Financial Covenants on Borrowings and Acceleration | EnBio Holdings,Inc (6092) | Komori